Skip to main content

Quest Diagnostics therapeutic area (TA) datasets are curated, indication-specific sets of clinical and genetic data, extracted from our comprehensive repository of over 70 billion lab results.

These deidentified datasets are meticulously designed and tailored to support various objectives across therapy development and provide flexibility across the enterprise.


Start your product’s journey to market with Quest

Quest deidentified data can be purchased directly from Quest and overlapped with other internal data sources or purchased through our preferred data partners to reach a desired patient cohort, ensuring minimal disruption to current workflows and processes.


Quest TA datasets provide clear insights

These datasets offer a unique blend of retrospective and prospective data, helping researchers and pharmaceutical companies to gain deep insights and drive the development and successful commercialization of next-generation therapies. 


Quest TA datasets address a broad spectrum of conditions

Quest Diagnostics offers comprehensive TA datasets across a wide range of key therapeutic areas, providing researchers and clinicians with invaluable tools to help drive innovation in treatment and care. Our datasets cover over 50 diseases and comprise clinical biomarkers, gene biomarkers, LOINC codes, and ICD codes. 

  • Acute lymphoblastic leukemia
  • Acute myelogenous leukemia
  • Adrenocortical cancer
  • Alzheimer’s disease
  • Appendiceal carcinoma
  • Basal cell carcinoma
  • Bile duct cancer
  • Bladder cancer
  • Brain cancer
  • Cardiomyopathy
  • Celiac disease
  • Cerebrovascular disease
  • Cervical cancer
  • Chlamydia genital infection
  • Chronic kidney disease
  • Chronic lymphocytic leukemia
  • Congenital heart disease
  • Coronary artery disease
  • Cystic nephroma
  • Lymphoma, diffuse large B-cell
  • Endocarditis inflammation
  • Endometrial cancer
  • Follicular lymphoma
  • Friedreich ataxia
  • Gallbladder cancer
  • Gastrointestinal cancer
  • Gastrointestinal stromal tumor
  • Gaucher disease
  • Giant cell arthritis
  • Gout
  • Guillain-Barre syndrome
  • Hashimoto disease
  • Heart failure
  • Hemolytic disease of the fetus and newborn
  • Hereditary paraganglioma-pheochromocytoma syndrome
  • Hodgkin lymphoma
  • Hyperkalemia
  • Hyperphosphatemia
  • Hypertensive heart disease
  • Hyperthyroidism
  • Hypothyroidism
  • Idiopathic inflammatory myopathy
  • Leiomyosarcomas
  • Leukemia
  • Lymphoblastic lymphoma
  • Mantle cell lymphoma
  • Meningioma
  • Mesothelioma
  • Myasthenia gravis
  • Neuroendocrine neoplasm
  • Obesity
  • Oropharyngeal cancer
  • Pancreatic cancer
  • Parathyroid cancer
  • Parkinson disease
  • Peripheral T-cell lymphoma
  • Pleuropulmonary blastoma
  • Testicular cancer
  • Thyroid cancer
  • Type 1 diabetes
  • Type 2 diabetes
  • Ureter cancer
  • Uterine cancer
  • Peripheral vascular disease
  • Primary hypertension
  • Psoriatic arthritis
  • Pulmonary heart disease
  • Renal artery stenosis
  • Sickle cell
  • Sjögren syndrome
  • Systemic lupus erythematosus
  • Thrombotic thrombocytopenic purpura
  • Warm autoimmune hemolytic anemia

Learn more about our datasets

To see the full list of biomarkers and tests included in our databases, please fill out the following form.

Please remember that email, including this web form, is not a secure method of communication. Do not submit personal information, including user names and passwords, social security numbers, or personal health information through this form.

882

* indicates required

The Quest advantage

 

Quest Diagnostics offers an unmatched scale and breadth of laboratory data, solidifying our position as the premier source for real-world evidence in therapeutic research.